Tmunity Therapeutics Funding: $231M Raised, Series B (2019)
Tmunity Therapeutics is based in Philadelphia. It has raised $231M in total funding. Latest round: Series B.
Tmunity Therapeutics funding overview
Tmunity Therapeutics is based in Philadelphia. Tmunity Therapeutics has raised $231M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in October 2019. The round record for Tmunity Therapeutics runs through 2019; nothing later has been disclosed. Investors on record include Andreessen Horowitz, Westlake Village BioPartners, Gilead Sciences, The University of Pennsylvania, Be The Match BioTherapies, BrightEdge. 6 distinct backers are named across the disclosed rounds.
Tmunity Therapeutics at a glance
Total raised
$231M
Latest round
Series B
Latest round date
October 2019
Headquarters
Philadelphia
Notable investors
Andreessen Horowitz, Westlake Village BioPartners, Gilead Sciences, The University of Pennsylvania, Be The Match BioTherapies, BrightEdge
Frequently asked about Tmunity Therapeutics funding
How much has Tmunity Therapeutics raised?
Tmunity Therapeutics has raised $231M in total disclosed funding across the rounds on record.
Who has invested in Tmunity Therapeutics?
Andreessen Horowitz, Westlake Village BioPartners, Gilead Sciences, The University of Pennsylvania, Be The Match BioTherapies, BrightEdge are named among the investors backing Tmunity Therapeutics.
What was the latest Tmunity Therapeutics funding round?
The most recent disclosed round is a Series B, announced in October 2019.
Where is Tmunity Therapeutics based?
Tmunity Therapeutics is based in Philadelphia.
When did Tmunity Therapeutics last raise?
The last disclosed Tmunity Therapeutics round closed in October 2019 at Series B.
We update the Tmunity Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Philadelphia and their backers are listed below.
